Elevance Health, Inc.
AT ˙ WBAG
SecurityAT:ELV / Elevance Health, Inc.
InstitutionSpears Abacus Advisors LLC
Latest Disclosed Ownership23,570 shares
Latest Disclosed Value $ 6,900,041
Spears Abacus Advisors LLC reports 60.64% increase in ownership of ELV / Elevance Health, Inc.

On May 15, 2026 - Spears Abacus Advisors LLC filed a 13F-HR/A form disclosing ownership of 23,570 shares of Elevance Health, Inc. (AT:ELV) valued at $6,900,041 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 14,673 shares of Elevance Health, Inc.. This represents a change in shares of 60.64% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F/A-1 ELEVANCE HEALTH INC FORMERLY COM 036752103 23,570 8,897 60.64 6,900 34.16 0.1353
2026-05-14 2026-03-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 23,568 8,895 6,712 0.1330
2026-02-17 2025-12-31 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 14,673 -594 -3.89 5,144 4.28 0.0962
2025-11-14 2025-09-30 13F ELEVANCE HEALTH INC FORMERLY COM 036752103 15,267 -11,137 -42.18 4,933 -51.97 0.0930
2025-08-14 2025-06-30 13F ELEVANCE HEALTH COM 036752103 26,404 176 0.67 10,270 -9.98 0.2074
2025-05-14 2025-03-31 13F ELEVANCE HEALTH COM 036752103 26,228 -2,194 -7.72 11,408 8.81 0.2456
2025-02-12 2024-12-31 13F ELEVANCE HEALTH COM 036752103 28,422 -37,810 -57.09 10,485 -69.56 0.2154
2024-11-12 2024-09-30 13F ELEVANCE HEALTH COM 036752103 66,232 -571 -0.85 34,441 -4.85 0.6778
2024-08-12 2024-06-30 13F ELEVANCE HEALTH COM 036752103 66,803 121 0.18 36,198 4.69 0.7510
2024-05-10 2024-03-31 13F ELEVANCE HEALTH COM 036752103 66,682 1,995 3.08 34,577 13.36 0.7149
2024-02-14 2023-12-31 13F ELEVANCE HEALTH COM 036752103 64,687 182 0.28 30,504 8.61 2.4287
2023-11-21 2023-09-30 13F ELEVANCE HEALTH COM 036752103 64,505 49 0.08 28,087 -1.92 2.4078
2023-08-14 2023-06-30 13F ELEVANCE HEALTH COM 036752103 64,456 59,858 1,301.83 28,637 1,254.64 2.3363
2023-05-15 2023-03-31 13F ELEVANCE HEALTH COM 036752103 4,598 4,598 2,114 0.1893
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.